Zobrazeno 1 - 9
of 9
pro vyhledávání: '"A L Small-Howard"'
Autor:
Michael G. Morash, Jessica Nixon, Lori M. N. Shimoda, Helen Turner, Alexander J. Stokes, Andrea L. Small-Howard, Lee D. Ellis
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Medicinal cannabis has shown promise for the symptomatic treatment of Parkinson’s disease (PD), but patient exposure to whole plant mixtures may be undesirable due to concerns around safety, consistency, regulatory issues, and psychoactivity. Ident
Externí odkaz:
https://doaj.org/article/4209c1573dbf455f9fcc70830700ff22
Autor:
Naghum Alfulaij, Franziska Meiners, Justin Michalek, Andrea L. Small‐Howard, Helen C. Turner, Alexander J. Stokes
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 14 (2018)
Externí odkaz:
https://doaj.org/article/b4ad6b406f2344ea85c1c009877475e7
Autor:
PS Tzimas, E A Petrakis, S Beteinakis, A N Martini, M Papafotiou, D Bilalis, A L Small-Howard, M Halabalaki, L A Skaltsounis
Publikováno v:
GA – 70th Annual Meeting 2022.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21bc5ee8872c19bb4065cb29588fecd2
https://doi.org/10.1055/s-0042-1759238
https://doi.org/10.1055/s-0042-1759238
Autor:
PS Tzimas, E A Petrakis, S Beteinakis, P Papastylianou, I Kakabouki, D Chandrinou, A L Small-Howard, D Bilalis, M Halabalaki, L A Skaltsounis
Publikováno v:
GA – 70th Annual Meeting 2022.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e9024efd6aecfde6cce80e5b3abc504
https://doi.org/10.1055/s-0042-1759053
https://doi.org/10.1055/s-0042-1759053
Autor:
Petros S. Tzimas, Eleftherios A. Petrakis, Stavros Beteinakis, Panayiota Papastylianou, Ioanna Kakabouki, Daphne Chandrinou, Andrea L. Small-Howard, Dimitrios Bilalis, Maria Halabalaki, Leandros A. Skaltsounis
Publikováno v:
Macedonian Pharmaceutical Bulletin. 68:133-134
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85eb61d9e28c64b127531ad96ee5dd17
https://doi.org/10.33320/maced.pharm.bull.2022.68.04.060
https://doi.org/10.33320/maced.pharm.bull.2022.68.04.060
Autor:
Lance K. Blevins, Anthony P. Bach, Robert B. Crawford, Jiajun Zhou, Joseph E. Henriquez, Michael D. Rizzo, Sera Sermet, D.M. Isha Olive Khan, Helen Turner, Andrea L. Small-Howard, Norbert E. Kaminski
Publikováno v:
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 170
Cannabis is well established as possessing immune modulating activity. The objective of this study was to evaluate the anti-inflammatory properties of selected cannabis-derived terpenes and cannabinoids. Based on their activity in cannabis-chemovar s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70a8cd2e3c5149c4d855b05cb36a2b14
https://pubmed.ncbi.nlm.nih.gov/36228902
https://pubmed.ncbi.nlm.nih.gov/36228902
Autor:
Mazen M. El-Hammadi, Andrea L. Small-Howard, Chad Jansen, Mercedes Fernández-Arévalo, Helen Turner, Lucía Martín-Banderas
Publikováno v:
idUS. Depósito de Investigación de la Universidad de Sevilla
instname
instname
The objective of these in vitro studies was to investigate the impact of the encapsulation of three cannabis-based terpenes, namely β-myrcene (MC), β-caryophyllene (CPh), and nerolidol (NL), on their potential efficacy in pain management. Terpene-e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f37037d1bdfe2607e83be3b151ba308
Autor:
Andrea L. Small-Howard, Mazen M. El-Hammadi, Lucía Martín-Banderas, Mercedes Fernández-Arévalo
Publikováno v:
Industrial Crops and Products. 164:113345
Terpenes derived from different varieties of Cannabis sativa have shown potentially useful pharmacological activities, including the ability to bind to transient receptor potential (TRP) channels. Beta-myrcene (MC), beta-caryophyllene (CPh), and nero
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbd8ce494f13d6c185aeb80a4293ab4a
https://doi.org/10.1016/j.indcrop.2021.113345
https://doi.org/10.1016/j.indcrop.2021.113345
Autor:
Holden Harris, Andrea L. Small-Howard
Publikováno v:
Journal of Immunoassay & Immunochemistry
The DR-70® (FDP) test was the first cancer test cleared by USFDA for monitoring colorectal cancer (CRC) since Carcinoembryonic Antigen (CEA) in 1982. Conservatively, 50% of biopsy-positive CRC patients have negative CEA values. DR-70 and CEA values
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1368ddb6bedb00e25e257c89f44d5948
https://doi.org/10.1080/15321811003617438
https://doi.org/10.1080/15321811003617438